Drug Database
TK

TK-129 (TK 129 / TK129)

✓ Approved

Foshan Rexiu Biotechnology · LRP1

什么是 TK-129?

TK-129 是一种治疗药物,由Foshan Rexiu Biotechnology研发。该药已获批,用于治疗相关适应症,给药途径:Unknown。

药物档案

商品名TK 129, TK129
公司Foshan Rexiu Biotechnology
分子靶点LRP1
给药途径Unknown
状态Approved

作用机制

分子靶点

TK-129 作用于 1 个分子靶点:

LRP1LDL receptor related protein 1 (LRP1A, A2MR)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

TK-129 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Rectosigmoid cancer✓ Approved

相关研究文献

PubMedNature aging2026-11-19

Comparing plasma p-tau217 and plasma p-tau217/Aβ42 with CSF biomarkers for assessing Alzheimer's disease pathology.

Warmenhoven Noëlle N, Binette Alexa Pichet AP, Collij Lyduine E LE, Janelidze Shorena S et al.

Plasma biomarkers for Alzheimer's disease (AD) on fully automated platforms offer accessible, cost-effective diagnostic tools. Here we aimed to compare Lumipulse plasma phospho-tau217 (p-tau217) and the p-tau217/beta-amyloid42 ratio (p-tau217/Aβ42) with regulatory-authorized cerebrospinal fluid (CSF) biomarkers (Aβ42/Aβ40 and p-tau181/Aβ42) for identifying AD pathology (Aβ-PET visual read) across a memory clinic (n = 129), a primary care (n = 220) and a research cohort (n = 165). Regulatory-authorized cutoffs were used for the plasma and CSF biomarkers. Plasma biomarkers identified Aβ pathology with areas under the curve between 0.90 and 0.96. Using one cutoff, plasma p-tau217 (83-91%) and p-tau217/Aβ42 (83-92%) had comparable accuracies to CSF (88-90%) across all cohorts (all P ≥ 0.05). With a two-cutoff approach, plasma p-tau217 (90-97%) remained comparable to CSF (91%) in the clinical cohorts (all Padj ≥ 0.12). Results with cohort-derived cutoffs are also provided. In conclusion, regulatory-authorized plasma p-tau217 and p-tau217/Aβ42 demonstrated performance comparable to regulatory-authorized CSF tests for detecting Aβ pathology in symptomatic individuals.

PMID 43052398
阅读全文 →
PubMedBMC ophthalmology2026-11-19

Traumatic cataract with secondary extreme axial elongation and posterior staphyloma: a case report.

Chen Yanchen Y, Li Shengnan S, Liu Qing Q, Liu Dongjing D et al.

Traumatic cataract complicated by secondary pathologic myopia and posterior staphyloma presents significant challenges to preoperative biometry accuracy and surgical strategy selection. Reports of complex cases involving long-standing trauma (> 30 years) with secondary extreme axial length (> 29 mm) and posterior staphyloma are rare, and systematic diagnostic and therapeutic experience remains limited. A 41-year-old male presented with a 30-year history of following a wooden stick injury. Left eye visual acuity was hand motion at 20 cm, with no improvement through either pinhole testing or refractive correction. His primary concerns included inability to perform fine visual tasks and progressive cosmetic deterioration due to esotropia. Notably, his elder sister had moderate myopia. Examination revealed characteristic "nine-petal" rosette-shaped lens opacification, an axial length of 29.99 mm, and secondary posterior staphyloma in the left eye. Diagnostic challenges included the inability to perform standard optical biometry due to the combination of dense lens opacity and posterior staphyloma, necessitating immersion B-mode ultrasound. Immersion B-mode ultrasound biometry was performed, and the Barrett TK Universal II formula was used to calculate intraocular lens (IOL) power with a target refraction of - 1.50 D. Uneventful phacoemulsification with capsular tension ring (CTR) implantation and IOL (+ 6.0 D) placement was performed. At 6-month follow-up, corrected distance visual acuity improved to 1.0 with a stable manifest refraction of - 1.75/-1.00 × 15°. No serious adverse events occurred; an unanticipated finding was a slight increase in esotropia with occasional diplopia, which did not compromise overall visual rehabilitation. Systematic evaluation (characteristic opacification identification, immersion ultrasound biometry, and assessment of secondary anatomic alterations) combined with individualized surgical strategy (CTR implantation and Barrett formula optimization) can achieve excellent visual outcomes even in the presence of secondary pathologic myopia and posterior staphyloma. This case provides clinical guidance for managing traumatic cataract with secondary anatomic alterations and highlights the critical value of precise biometry and capsular stability management in complex cases.

PMID 43052856
阅读全文 →
PubMedConflict and health2026-11-19

Magnitude of precancerous cervical lesions in a fragile and conflict-affected setting: the case of Tigray region, Ethiopia.

Jacks Courtney C, Abebe Gebreamlak Gidey GG, Berhe Almaz A, Asres Negasi N et al.

Cervical cancer remains a major public health concern, ranking as the fourth leading cause of cancer-related deaths among women globally and the second in Ethiopia. Limited access to routine screening, exacerbated by the Tigray war (November 2020-November 2022), has contributed to delayed detection and treatment. This study aimed to identify factors associated with precancerous cervical lesions among women screened in a fragile and conflict-affected setting. A facility-based cross-sectional study was conducted among 6,279 women who underwent cervical cancer screening using Visual Inspection with Acetic Acid (VIA) at public health institutions in Mekelle, Tigray, between July 15, 2023, and January 15, 2024. Data were collected using the KOBO toolbox, and logistic regression was used to assess associations between VIA positivity and demographic and behavioral risk factors. Among participants, 975 (15.5%) tested VIA positive (diagnosed with precancerous lesions), 5175 (82.4%) tested VIA negative, and 129 (2.1%) were suspicious of cancer. Women with secondary education (grades 9-12) had lower odds of VIA positivity compared to illiterate women (AOR = 0.74; 95% CI: 0.58-0.93). Higher odds were observed in women with ≥ 2 sexual partners (AOR = 1.93; 95% CI: 1.65-2.25), early sexual debut (< 18 years) (AOR = 2.84; 95% CI: 2.44-3.20), history of painful intercourse (AOR = 1.67; 95% CI: 1.31-2.13), sexually transmitted infections (AOR = 1.80; 95% CI: 1.45-2.23), and post-coital bleeding (AOR = 2.55; 95% CI: 1.37-4.75). Follow-up screening visits were associated with lower VIA positivity (AOR = 0.55; 95% CI: 0.42-0.7). Despite the end of the Tigray war, persistent risk factors and reduced screening access remain associated with patterns of cervical cancer detection. Strengthening screening programs and expanding HPV vaccination-especially for high-risk groups-is essential to reduce cervical cancer burden in the region.

PMID 43053080
阅读全文 →
PubMedBMC cancer2026-11-19

Efficacy and safety of [¹⁷⁷Lu]Lu-DOTA-TATE versus standard systemic therapies in advanced well-differentiated gastroenteropancreatic neuroendocrine tumors: a retrospective cohort study.

Zhao Shuqiang S, Kou Shufang S

Advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) present a therapeutic challenge due to their heterogeneity and variable response to systemic therapies. This study aimed to evaluate the real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) with [¹⁷⁷Lu]Lu-DOTA-TATE in patients with advanced well-differentiated GEP-NETs. This retrospective cohort study included 129 patients diagnosed with advanced well-differentiated GEP-NETs between January 2022 and December 2025. Patients were classified into two groups according to treatment strategy: the [¹⁷⁷Lu]Lu-DOTA-TATE group (n = 65) and the control group (n = 64), who received standard systemic therapies without PRRT. The primary endpoints were overall survival (OS) and progression-free survival (PFS). Secondary outcomes included objective response rate (ORR), disease control rate (DCR), and treatment-related adverse events. Prognostic factors for OS and PFS were evaluated using Cox regression analyses. The median duration of follow-up was 34.6 months (1.3-45.7) in the [¹⁷⁷Lu]Lu-DOTA-TATE group and 25.8 months (0.9-45.6) in the control group. The [¹⁷⁷Lu]Lu-DOTA-TATE group demonstrated significantly longer median OS (34.6 vs. 25.8 months; P = 0.046) and median PFS (22.0 vs. 16.7 months; P = 0.008) compared with the control group. ORR showed a trend toward improvement (P = 0.118), while DCR was significantly higher in the [¹⁷⁷Lu]Lu-DOTA-TATE group (P = 0.026). The overall incidence of adverse events and the rates of grade ≥ 3 adverse events were comparable between groups (P > 0.05). Multivariable analysis identified [¹⁷⁷Lu]Lu-DOTA-TATE treatment, younger age, lower Ki-67 index, and lower tumor grade as independent predictors of improved OS or PFS. [¹⁷⁷Lu]Lu-DOTA-TATE provides meaningful survival benefits with acceptable safety in patients with advanced well-differentiated GEP-NETs, supporting its integration into real-world treatment strategies and warranting further prospective validation.

PMID 43052866
阅读全文 →
PubMedBMC urology2026-11-19

The prognostic impact of variant histology timing in bladder cancer: a comparative analysis of primary and secondary detection.

Dama Mertcan M, Ahmadzada Javid J, Efiloglu Ozgur O, Bozkurt Yunus Erol YE et al.

Variant/subtype histology (V/SH) in bladder cancer is associated with distinct clinical behaviour and adverse oncological outcomes. However, the prognostic significance of the timing of V/SH detection - whether present at initial diagnosis (primary V/SH) or emerging during follow-up (secondary V/SH) - remains unclear. This retrospective, single-centre study aimed to compare clinical characteristics and survival outcomes between patients with primary and secondary V/SH in bladder cancer, with particular attention to the potential influence of immortal time bias. Data from all consecutive 1,120 bladder cancer patients who underwent transurethral resection or radical cystectomy between 2015 and 2024 were retrospectively evaluated. Of these, 171 patients were identified with V/SH and categorised as primary V/SH (n = 129) or secondary V/SH (n = 42). Kaplan-Meier analysis with log-rank testing and multivariable Cox proportional hazards regression were performed to assess cancer-specific (CSS) and overall survival (OS). A total of 57 cancer-specific deaths were recorded. Patients with secondary V/SH had significantly longer follow-up (median 54.0 vs. 10.0 months, p = 0.001) and higher rates of recurrence (93% vs. 46%, p = 0.001) and progression (86% vs. 54%, p = 0.001). Unadjusted analyses showed significant differences in CSS (p = 0.021) and OS (p = 0.002). In a time-fixed multivariable Cox model, timing was not an independent predictor of CSS (HR: 0.59, 95% CI: 0.29-1.20, p = 0.146). However, in a time-dependent Cox regression model accounting for immortal time bias, secondary V/SH status showed a trend toward increased cancer-specific mortality (HR: 1.84, 95% CI: 0.88-3.84, p = 0.104), a directionally different result from the time-fixed model. The prognostic significance of variant histology timing appeared sensitive to the analytical approach used, with time-fixed and time-dependent models yielding directionally different, non-significant estimates, highlighting the importance of accounting for immortal time bias in similar retrospective study designs. Tumour size and intravesical therapy consistently emerged as independent prognostic factors across all models. These findings suggest an individualised, risk-adapted approach based on tumour characteristics. Larger, prospective, multicentre studies are warranted to clarify the true prognostic role of variant histology timing.

PMID 43052964
阅读全文 →
PubMedBMC pregnancy and childbirth2026-11-19

Previous cesarean characteristics among women with and without cesarean scar pregnancy: an exploratory hospital-based case-control study in Vietnam.

Thuong Bui Chi BC, Duyen Nguyen Thi My NTM, Nguyen Pham Dinh PD

Cesarean scar pregnancy (CSP) is a high-risk ectopic pregnancy after cesarean delivery. Whether the recorded timing of a previous cesarean delivery in relation to labor is associated with CSP remains uncertain. We conducted an unmatched exploratory hospital-based case-control study in Ho Chi Minh City, Vietnam (November 2023 to April 2024). Cases had a first-trimester ultrasound diagnosis of CSP. Controls were first-trimester hospital antenatal attendees with a previous cesarean delivery and an intrauterine pregnancy not classified as CSP, enrolled against accruing cases to a fixed 1:3 quota rather than sampled from an enumerated frame. The primary exposure was the recorded prelabor classification of the most recent cesarean delivery, as retained in the study dataset. Analyses comprised crude comparisons, a parsimonious Firth penalized logistic regression, two restricted analyses, and sensitivity analyses. The sample comprised 59 CSP cases and 177 controls. The recorded prelabor classification was more frequent among cases (37/59, 62.7%) than controls (55/177, 31.1%; crude odds ratio [OR] 3.73 95% confidence interval [CI] 2.01-6.91). Adjusted for maternal age and number of previous cesarean deliveries, the Firth OR was 2.62 (95% CI 1.33-5.19; p = 0.006). Restricted to one prior birth: 10/12 versus 31/129 (OR 15.81, 95% CI 3.29-76.05); restricted to exactly one previous cesarean delivery: 14/21 versus 39/145 (OR 5.44, 95% CI 2.04-14.47). These strata are nested, not independent replications. Two descriptive observations were directly available from the retained dataset: 59 of 177 controls (33.3%) were in the closest recorded sac-to-scar distance category (< 20 mm) without meeting ultrasound criteria for CSP, and 18 of 59 cases (30.5%) were asymptomatic at presentation. In this included hospital-based sample, the recorded prelabor classification was associated with CSP after penalized adjustment and in restricted analyses. These findings are exploratory and hypothesis-generating and cannot establish an independent causal effect: the study base could not be established, inclusion in the final analytical dataset required ascertainable information on the previous-cesarean timing and indication, comparable pre-enrolment control screening and exclusion data were unavailable, exposure provenance is not reconstructible, and central image re-review was not possible. The two descriptive findings support careful first-trimester pregnancy localization after cesarean delivery. Screening effectiveness, diagnostic accuracy and treatment outcomes were not evaluated.

PMID 43052824
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多TK-129